Retour

SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

Calendar Calendar of Events

SANTA CLARA, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2024 BofA Securities Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 14, at 2:20 p.m. Eastern Time / 11:20 a.m. Pacific Time.

GlobeNewswire Inc. • 29/04/2024 à 15:00:00
SI-BONE, Inc. Common Stock
Address: 471 EL CAMINO REAL, SUITE 101
Postal Code: 95050
City: SANTA CLARA
State: CA
Phone Number: (408) 207-0700
Website: https://www.si-bone.com
Status: Active
Company Info

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

List Date2018-10-17
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001459839
Composite figiBBG001J414K6
Share Class figiBBG001V0GNP7
Market Cap631,669,523 USD
SIC Code3841
SIC DescriptionSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Total Employees344
Share Class Shares Outstanding41210000
Weighted Shares Outstanding41204796
Round Lot100
Updated date2024-05-12
Stats
Last 5 days
15-05
14-05
13-05
10-05
9-05
Last
15.115
14.68
15.135
15.32
15.549
Variance
2.8%
-3.17%
-1.24%
-1.28%
3.52%
Open
14.704
15.16
15.325
15.519
15.02
Highest
15.115
15.335
15.64
15.756
15.62
Lowest
15.115
15.324
15.604
15.677
15.62
History
PeriodVarhighestlowest
1 week
0.9%
15.62
15.115
1 month
-46.24%
28.19
14.501
3 month
-28.06%
21.56
14.501
6 month
-28.06%
21.56
14.501
1 year
-28.06%
21.56
14.501
3 year
-28.06%
21.56
14.501
5 year
-28.06%
21.56
14.501
10 year
-28.06%
21.56
14.501
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-02 2023-08-08 2023-11-07 UNPUB
Assets 149,076,000 233,825,000 230,878,000 UNPUB
Current Assets 128,401,000 212,534,000 211,019,000 UNPUB
Current Liabilities 16,628,000 18,202,000 19,372,000 UNPUB
Equity 93,959,000 177,407,000 173,600,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 93,959,000 177,407,000 173,600,000 UNPUB
Liabilities 55,117,000 56,418,000 57,278,000 UNPUB
Liabilities And Equity 149,076,000 233,825,000 230,878,000 UNPUB
Noncurrent Assets 20,675,000 21,291,000 19,859,000 UNPUB
Noncurrent Liabilities 38,489,000 38,216,000 37,906,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-02 2023-08-08 2023-11-07 UNPUB
Exchange Gains/Losses 97,000 32,000 -143,000 UNPUB
Net Cash Flow 2,252,000 87,846,000 -57,323,000 UNPUB
Net Cash Flow, Continuing 2,155,000 87,814,000 -57,180,000 UNPUB
Net Cash Flow From Financing Activities 1,205,000 89,123,000 -237,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 1,205,000 89,123,000 -237,000 UNPUB
Net Cash Flow From Investing Activities 11,703,000 2,281,000 -54,870,000 UNPUB
Net Cash Flow From Investing Activities, Continuing 11,703,000 2,281,000 -54,870,000 UNPUB
Net Cash Flow From Operating Activities -10,753,000 -3,590,000 -2,073,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -10,753,000 -3,590,000 -2,073,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-02 2023-08-08 2023-11-07 UNPUB
Comprehensive Income/Loss -11,057,000 -11,208,000 -9,964,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -11,057,000 -11,208,000 -9,964,000 UNPUB
Other Comprehensive Income/Loss -11,057,000 -11,208,000 -9,964,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-02 2023-08-08 2023-11-07 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 0 0 0 UNPUB
Cost Of Revenue 5,924,000 6,318,000 7,041,000 UNPUB
Costs And Expenses 44,001,000 45,268,000 45,183,000 UNPUB
Diluted Earnings Per Share 0 0 0 UNPUB
Gross Profit 26,784,000 26,987,000 26,973,000 UNPUB
Income/Loss From Continuing Operations After Tax -11,125,000 -11,206,000 -10,022,000 UNPUB
Income/Loss From Continuing Operations Before Tax 32,708,000 33,305,000 34,014,000 UNPUB
Income Tax Expense/Benefit 0 0 0 UNPUB
Interest Expense, Operating 838,000 850,000 884,000 UNPUB
Net Income/Loss -11,125,000 -11,206,000 -10,022,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -11,125,000 -11,206,000 -10,022,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -11,125,000 -11,206,000 -10,022,000 UNPUB
Operating Expenses 38,077,000 38,950,000 38,142,000 UNPUB
Operating Income/Loss -11,293,000 -11,963,000 -11,169,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 32,708,000 33,305,000 34,014,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 UNPUB 2022-11-08 2023-03-02
Assets 176,849,000 UNPUB 158,265,000 157,552,000
Current Assets 161,261,000 UNPUB 139,180,000 137,611,000
Current Liabilities 15,453,000 UNPUB 18,564,000 21,178,000
Equity 122,438,000 UNPUB 102,828,000 98,302,000
Equity Attributable To Noncontrolling Interest 0 UNPUB 0 0
Equity Attributable To Parent 122,438,000 UNPUB 102,828,000 98,302,000
Liabilities 54,411,000 UNPUB 55,437,000 59,250,000
Liabilities And Equity 176,849,000 UNPUB 158,265,000 157,552,000
Noncurrent Assets 15,588,000 UNPUB 19,085,000 19,941,000
Noncurrent Liabilities 0 UNPUB 36,873,000 38,072,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 UNPUB 2022-11-08 2023-03-02
Exchange Gains/Losses -139,000 UNPUB UNPUB -429,000
Net Cash Flow -36,090,000 UNPUB UNPUB -42,702,000
Net Cash Flow, Continuing -35,951,000 UNPUB UNPUB -42,273,000
Net Cash Flow From Financing Activities 169,000 UNPUB UNPUB 2,197,000
Net Cash Flow From Financing Activities, Continuing 169,000 UNPUB UNPUB 2,197,000
Net Cash Flow From Investing Activities -22,608,000 UNPUB UNPUB -2,815,000
Net Cash Flow From Investing Activities, Continuing -22,608,000 UNPUB UNPUB -2,815,000
Net Cash Flow From Operating Activities -13,512,000 UNPUB UNPUB -41,655,000
Net Cash Flow From Operating Activities, Continuing -13,512,000 UNPUB UNPUB -41,655,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 UNPUB 2022-11-08 2023-03-02
Comprehensive Income/Loss -17,410,000 UNPUB -14,033,000 -61,376,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 UNPUB 0 0
Comprehensive Income/Loss Attributable To Parent -17,658,000 UNPUB -14,033,000 -61,376,000
Other Comprehensive Income/Loss 0 UNPUB -14,033,000 -61,376,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 UNPUB 2022-11-08 2023-03-02
Basic Earnings Per Share -1 UNPUB 0 -2
Benefits Costs and Expenses 0 UNPUB 0 0
Cost Of Revenue 2,983,000 UNPUB 4,168,000 15,705,000
Costs And Expenses 39,307,000 UNPUB 39,998,000 166,018,000
Diluted Earnings Per Share -1 UNPUB 0 -2
Gross Profit 19,456,000 UNPUB 22,264,000 90,704,000
Income/Loss From Continuing Operations After Tax -17,410,000 UNPUB -14,158,000 -61,256,000
Income/Loss From Continuing Operations Before Tax -17,410,000 UNPUB 26,432,000 106,409,000
Income Tax Expense/Benefit UNPUB UNPUB 0 15,990,000
Interest Expense, Operating 561,000 UNPUB 755,000 2,819,000
Net Income/Loss -17,410,000 UNPUB -14,158,000 -61,256,000
Net Income/Loss Attributable To Noncontrolling Interest 0 UNPUB 0 0
Net Income/Loss Attributable To Parent -17,410,000 UNPUB -14,158,000 -61,256,000
Net Income/Loss Available To Common Stockholders, Basic -17,410,000 UNPUB -14,158,000 -61,256,000
Operating Expenses 36,324,000 UNPUB 35,830,000 150,313,000
Operating Income/Loss -16,868,000 UNPUB -13,566,000 -59,609,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 UNPUB 0 0
Preferred Stock Dividends And Other Adjustments 0 UNPUB 0 0
Revenues 22,439,000 UNPUB 26,432,000 106,409,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-04 2021-11-09 2022-03-01
Assets 215,761,000 207,332,000 193,966,000 190,506,000
Current Assets 208,110,000 199,112,000 185,648,000 175,866,000
Current Liabilities 13,708,000 12,624,000 14,564,000 16,890,000
Equity 161,667,000 154,198,000 143,618,000 134,420,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 161,667,000 154,198,000 143,618,000 134,420,000
Liabilities 54,094,000 53,134,000 50,348,000 56,086,000
Liabilities And Equity 215,761,000 207,332,000 193,966,000 190,506,000
Noncurrent Assets 7,651,000 8,220,000 8,318,000 14,640,000
Noncurrent Liabilities 0 0 35,784,000 39,196,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-04 2021-11-09 2022-03-01
Exchange Gains/Losses -337,000 125,000 -163,000 -498,000
Net Cash Flow -16,217,000 10,761,000 11,738,000 9,838,000
Net Cash Flow, Continuing -15,880,000 10,636,000 11,901,000 10,336,000
Net Cash Flow From Financing Activities 601,000 2,216,000 -5,543,000 -1,711,000
Net Cash Flow From Financing Activities, Continuing 601,000 2,216,000 -5,543,000 -1,711,000
Net Cash Flow From Investing Activities -7,122,000 16,571,000 26,753,000 51,580,000
Net Cash Flow From Investing Activities, Continuing -7,122,000 16,571,000 26,753,000 51,580,000
Net Cash Flow From Operating Activities -9,359,000 -8,151,000 -9,309,000 -39,533,000
Net Cash Flow From Operating Activities, Continuing -9,359,000 -8,151,000 -9,309,000 -39,533,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-04 2021-11-09 2022-03-01
Comprehensive Income/Loss -12,242,000 -13,981,000 -15,906,000 -56,744,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -12,336,000 -13,951,000 -15,906,000 -56,744,000
Other Comprehensive Income/Loss 0 0 -15,906,000 -56,744,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-04 2021-11-09 2022-03-01
Basic Earnings Per Share 0 0 0 -2
Benefits Costs and Expenses 0 0 0 0
Cost Of Revenue 2,200,000 2,375,000 2,478,000 10,428,000
Costs And Expenses 32,017,000 35,159,000 35,485,000 141,822,000
Diluted Earnings Per Share 0 0 0 -2
Gross Profit 18,242,000 19,819,000 19,808,000 79,724,000
Income/Loss From Continuing Operations After Tax -12,242,000 -13,981,000 -15,872,000 -56,572,000
Income/Loss From Continuing Operations Before Tax -12,242,000 -13,981,000 22,286,000 90,152,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 15,333,000
Interest Expense, Operating 1,064,000 1,075,000 2,658,000 5,365,000
Net Income/Loss -12,242,000 -13,981,000 -15,872,000 -56,572,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -12,242,000 -13,981,000 -15,872,000 -56,572,000
Net Income/Loss Available To Common Stockholders, Basic -12,242,000 -13,981,000 -15,872,000 -56,572,000
Operating Expenses 29,817,000 32,784,000 33,007,000 131,394,000
Operating Income/Loss -11,575,000 -12,965,000 -13,199,000 -51,670,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 20,442,000 22,194,000 22,286,000 90,152,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-05 2020-08-04 2020-11-03 2021-03-10
Assets 167,819,000 159,248,000 154,315,000 223,142,000
Current Assets 161,964,000 154,529,000 149,522,000 218,241,000
Current Liabilities 20,592,000 11,727,000 11,821,000 13,470,000
Equity 116,270,000 107,868,000 102,031,000 169,363,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 116,270,000 107,868,000 102,031,000 169,363,000
Liabilities 51,549,000 51,380,000 52,284,000 53,779,000
Liabilities And Equity 167,819,000 159,248,000 154,315,000 223,142,000
Noncurrent Assets 5,855,000 4,719,000 4,793,000 4,901,000
Noncurrent Liabilities 0 0 40,463,000 40,309,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-05 2020-08-04 2020-11-03 2021-03-10
Exchange Gains/Losses -3,000 9,000 69,000 323,000
Net Cash Flow 57,133,000 -1,399,000 -10,173,000 43,146,000
Net Cash Flow, Continuing 57,136,000 -1,408,000 -10,242,000 42,823,000
Net Cash Flow From Financing Activities 63,152,000 -256,000 467,000 136,401,000
Net Cash Flow From Financing Activities, Continuing 63,152,000 -256,000 467,000 136,401,000
Net Cash Flow From Investing Activities 3,339,000 6,721,000 -5,157,000 -62,916,000
Net Cash Flow From Investing Activities, Continuing 3,339,000 6,721,000 -5,157,000 -62,916,000
Net Cash Flow From Operating Activities -9,355,000 -7,873,000 -5,552,000 -30,662,000
Net Cash Flow From Operating Activities, Continuing -9,355,000 -7,873,000 -5,552,000 -30,662,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-05 2020-08-04 2020-11-03 2021-03-10
Comprehensive Income/Loss -12,772,000 -12,472,000 -9,654,000 -43,637,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -12,539,000 -12,559,000 -9,654,000 -43,637,000
Other Comprehensive Income/Loss 0 0 -9,654,000 -43,637,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-05 2020-08-04 2020-11-03 2021-03-10
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 117,084,000
Cost Of Revenue 1,932,000 2,117,000 2,578,000 8,902,000
Costs And Expenses 28,703,000 24,188,000 29,048,000 117,084,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 14,889,000 11,932,000 17,795,000 64,485,000
Income/Loss From Continuing Operations After Tax -12,772,000 -12,472,000 -9,474,000 -56,846,000
Income/Loss From Continuing Operations Before Tax -12,772,000 -12,472,000 20,373,000 -43,697,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 13,149,000
Interest Expense, Operating 1,231,000 2,683,000 1,102,000 6,101,000
Net Income/Loss -12,772,000 -12,472,000 -9,474,000 -43,697,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -12,772,000 -12,472,000 -9,474,000 -43,697,000
Net Income/Loss Available To Common Stockholders, Basic -12,772,000 -12,472,000 -9,474,000 -43,697,000
Operating Expenses 26,771,000 22,071,000 26,470,000 103,052,000
Operating Income/Loss -11,882,000 -10,139,000 -8,675,000 -38,567,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 16,821,000 14,049,000 20,373,000 73,387,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-09 2019-08-07 2019-11-12 2020-03-11
Assets 132,054,000 127,122,000 121,316,000 117,009,000
Current Assets 129,397,000 119,018,000 112,713,000 111,462,000
Current Liabilities 9,908,000 9,919,000 12,834,000 18,774,000
Equity 82,755,000 77,747,000 68,961,000 63,008,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 82,755,000 77,747,000 68,961,000 63,008,000
Liabilities 49,299,000 49,375,000 52,355,000 54,001,000
Liabilities And Equity 132,054,000 127,122,000 121,316,000 117,009,000
Noncurrent Assets 2,657,000 8,104,000 8,603,000 5,547,000
Noncurrent Liabilities 0 0 39,521,000 35,227,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-09 2019-08-07 2019-11-12 2020-03-11
Exchange Gains/Losses -53,000 49,000 -60,000 -37,000
Net Cash Flow -12,559,000 -1,065,000 1,118,000 -14,685,000
Net Cash Flow, Continuing -12,506,000 -1,114,000 1,178,000 -14,648,000
Net Cash Flow From Financing Activities 125,000 1,538,000 573,000 3,488,000
Net Cash Flow From Financing Activities, Continuing 125,000 1,538,000 573,000 3,488,000
Net Cash Flow From Investing Activities -5,553,000 5,744,000 7,725,000 13,491,000
Net Cash Flow From Investing Activities, Continuing -5,553,000 5,744,000 7,725,000 13,491,000
Net Cash Flow From Operating Activities -7,078,000 -8,396,000 -7,120,000 -31,627,000
Net Cash Flow From Operating Activities, Continuing -7,078,000 -8,396,000 -7,120,000 -31,627,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-09 2019-08-07 2019-11-12 2020-03-11
Comprehensive Income/Loss -9,345,000 -8,654,000 -11,347,000 -38,378,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -9,339,000 -8,583,000 -11,347,000 -38,378,000
Other Comprehensive Income/Loss 0 0 -11,347,000 -38,378,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-09 2019-08-07 2019-11-12 2020-03-11
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 0 0 0 105,704,000
Cost Of Revenue 1,526,000 1,588,000 1,630,000 6,790,000
Costs And Expenses 23,790,000 24,455,000 26,763,000 105,704,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 13,465,000 14,729,000 14,552,000 60,511,000
Income/Loss From Continuing Operations After Tax -9,345,000 -8,654,000 -11,306,000 -48,295,000
Income/Loss From Continuing Operations Before Tax -9,345,000 -8,654,000 16,182,000 -38,403,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 9,892,000
Interest Expense, Operating 1,230,000 1,233,000 1,243,000 4,949,000
Net Income/Loss -9,345,000 -8,654,000 -11,306,000 -38,403,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -9,345,000 -8,654,000 -11,306,000 -38,403,000
Net Income/Loss Available To Common Stockholders, Basic -9,345,000 -8,654,000 -11,306,000 -38,403,000
Operating Expenses 22,264,000 22,867,000 25,133,000 96,514,000
Operating Income/Loss -8,799,000 -8,138,000 -10,581,000 -36,003,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 14,991,000 16,317,000 16,182,000 67,301,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2019-03-14
Assets UNPUB UNPUB UNPUB 138,521,000
Current Assets UNPUB UNPUB UNPUB 136,042,000
Current Liabilities UNPUB UNPUB UNPUB 9,006,000
Equity UNPUB UNPUB UNPUB 90,192,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 90,192,000
Liabilities UNPUB UNPUB UNPUB 48,329,000
Liabilities And Equity UNPUB UNPUB UNPUB 138,521,000
Noncurrent Assets UNPUB UNPUB UNPUB 2,479,000
Noncurrent Liabilities UNPUB UNPUB UNPUB 39,323,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2019-03-14
Exchange Gains/Losses UNPUB UNPUB UNPUB -94,000
Net Cash Flow UNPUB UNPUB UNPUB 2,712,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB 2,806,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 115,150,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 115,150,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -97,825,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -97,825,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -14,519,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -14,519,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2019-03-14
Comprehensive Income/Loss UNPUB UNPUB UNPUB -17,416,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -17,416,000
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB -17,416,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2019-03-14
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB 72,833,000
Cost Of Revenue UNPUB UNPUB UNPUB 4,833,000
Costs And Expenses UNPUB UNPUB UNPUB 72,833,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB 50,547,000
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB -22,030,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB -17,453,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 4,577,000
Interest Expense, Operating UNPUB UNPUB UNPUB 5,108,000
Net Income/Loss UNPUB UNPUB UNPUB -17,453,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -17,453,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB -17,453,000
Operating Expenses UNPUB UNPUB UNPUB 62,512,000
Operating Income/Loss UNPUB UNPUB UNPUB -11,965,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 0
Revenues UNPUB UNPUB UNPUB 55,380,000
Calendar
16 May 2024 (Time UTC) Actual Previous Consensus
★
15:50
United States
★★
11:30
United States
★
11:30
United States
5.275
★
11:30
United States
5.270
★
11:30
United States
★
11:30
United States
★★
10:30
United States
★
10:30
United States
MAY 10
70000000000.000
79000000000.000
76000000000.000
★
10:30
United States
MAY 10
★★
10:00
United States
★
09:15
United States
APR
-0.300
0.200
0.100
★★
09:15
United States
APR
-0.380
0.090
★
09:15
United States
APR
78.400
78.500
78.400
★
09:15
United States
APR
★★
08:30
United States
APR
0.500
0.100
0.400
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:SIBN240419P00030000 OPASPS Put American 100 30 BATO 2024-04-19
O:SIBN240419P00025000 OPASPS Put American 100 25 BATO 2024-04-19
O:SIBN240419P00022500 OPASPS Put American 100 22.5 BATO 2024-04-19
O:SIBN240419P00020000 OPASPS Put American 100 20 BATO 2024-04-19
O:SIBN240419P00017500 OPASPS Put American 100 17.5 BATO 2024-04-19
O:SIBN240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:SIBN240419P00012500 OPASPS Put American 100 12.5 BATO 2024-04-19
O:SIBN240419C00030000 OCASPS Call American 100 30 BATO 2024-04-19
O:SIBN240419C00025000 OCASPS Call American 100 25 BATO 2024-04-19
O:SIBN240419C00022500 OCASPS Call American 100 22.5 BATO 2024-04-19
O:SIBN240419C00020000 OCASPS Call American 100 20 BATO 2024-04-19
O:SIBN240419C00017500 OCASPS Call American 100 17.5 BATO 2024-04-19
O:SIBN240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:SIBN240419C00012500 OCASPS Call American 100 12.5 BATO 2024-04-19
O:SIBN240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:SIBN240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:SIBN240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:SIBN240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:SIBN240419P00035000 OPASPS Put American 100 35 BATO 2024-04-19
O:SIBN240419P00010000 OPASPS Put American 100 10 BATO 2024-04-19
O:SIBN240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:SIBN240419C00035000 OCASPS Call American 100 35 BATO 2024-04-19
O:SIBN240419C00010000 OCASPS Call American 100 10 BATO 2024-04-19
O:SIBN240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:SIBN240315P00017500 OPASPS Put American 100 17.5 BATO 2024-03-15
O:SIBN240315P00015000 OPASPS Put American 100 15 BATO 2024-03-15
O:SIBN240315P00012500 OPASPS Put American 100 12.5 BATO 2024-03-15
O:SIBN240315P00010000 OPASPS Put American 100 10 BATO 2024-03-15
O:SIBN240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:SIBN240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:SIBN240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:SIBN240315C00035000 OCASPS Call American 100 35 BATO 2024-03-15
O:SIBN240315C00030000 OCASPS Call American 100 30 BATO 2024-03-15
O:SIBN240315C00025000 OCASPS Call American 100 25 BATO 2024-03-15
O:SIBN240315C00022500 OCASPS Call American 100 22.5 BATO 2024-03-15
O:SIBN240315C00020000 OCASPS Call American 100 20 BATO 2024-03-15
O:SIBN240315C00017500 OCASPS Call American 100 17.5 BATO 2024-03-15
O:SIBN240315C00015000 OCASPS Call American 100 15 BATO 2024-03-15
O:SIBN240315C00012500 OCASPS Call American 100 12.5 BATO 2024-03-15
O:SIBN240315C00010000 OCASPS Call American 100 10 BATO 2024-03-15
O:SIBN240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:SIBN240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:SIBN240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:SIBN240315P00035000 OPASPS Put American 100 35 BATO 2024-03-15
O:SIBN240315P00030000 OPASPS Put American 100 30 BATO 2024-03-15
O:SIBN240315P00025000 OPASPS Put American 100 25 BATO 2024-03-15
O:SIBN240315P00022500 OPASPS Put American 100 22.5 BATO 2024-03-15
O:SIBN240315P00020000 OPASPS Put American 100 20 BATO 2024-03-15
O:SIBN240216P00035000 OPASPS Put American 100 35 BATO 2024-02-16
O:SIBN240216P00030000 OPASPS Put American 100 30 BATO 2024-02-16
O:SIBN240216P00025000 OPASPS Put American 100 25 BATO 2024-02-16
O:SIBN240216P00022500 OPASPS Put American 100 22.5 BATO 2024-02-16
O:SIBN240216P00020000 OPASPS Put American 100 20 BATO 2024-02-16
O:SIBN240216P00017500 OPASPS Put American 100 17.5 BATO 2024-02-16
O:SIBN240216P00015000 OPASPS Put American 100 15 BATO 2024-02-16
O:SIBN240216P00012500 OPASPS Put American 100 12.5 BATO 2024-02-16
O:SIBN240216P00010000 OPASPS Put American 100 10 BATO 2024-02-16
O:SIBN240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:SIBN240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:SIBN240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:SIBN240216C00035000 OCASPS Call American 100 35 BATO 2024-02-16
O:SIBN240216C00030000 OCASPS Call American 100 30 BATO 2024-02-16
O:SIBN240216C00025000 OCASPS Call American 100 25 BATO 2024-02-16
O:SIBN240216C00022500 OCASPS Call American 100 22.5 BATO 2024-02-16
O:SIBN240216C00020000 OCASPS Call American 100 20 BATO 2024-02-16
O:SIBN240216C00017500 OCASPS Call American 100 17.5 BATO 2024-02-16
O:SIBN240216C00015000 OCASPS Call American 100 15 BATO 2024-02-16
O:SIBN240216C00012500 OCASPS Call American 100 12.5 BATO 2024-02-16
O:SIBN240216C00010000 OCASPS Call American 100 10 BATO 2024-02-16
O:SIBN240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:SIBN240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:SIBN240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:SIBN240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:SIBN240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:SIBN240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:SIBN240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:SIBN240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:SIBN240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:SIBN240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:SIBN240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:SIBN240119P00040000 OPASPS Put American 100 40 BATO 2024-01-19
O:SIBN240119P00035000 OPASPS Put American 100 35 BATO 2024-01-19
O:SIBN240119P00030000 OPASPS Put American 100 30 BATO 2024-01-19
O:SIBN240119P00025000 OPASPS Put American 100 25 BATO 2024-01-19
O:SIBN240119P00022500 OPASPS Put American 100 22.5 BATO 2024-01-19
O:SIBN240119P00020000 OPASPS Put American 100 20 BATO 2024-01-19
O:SIBN240119P00017500 OPASPS Put American 100 17.5 BATO 2024-01-19
O:SIBN240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:SIBN240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:SIBN240119C00040000 OCASPS Call American 100 40 BATO 2024-01-19
O:SIBN240119C00035000 OCASPS Call American 100 35 BATO 2024-01-19
O:SIBN240119C00030000 OCASPS Call American 100 30 BATO 2024-01-19
O:SIBN240119C00025000 OCASPS Call American 100 25 BATO 2024-01-19
O:SIBN240119C00022500 OCASPS Call American 100 22.5 BATO 2024-01-19
O:SIBN240119C00020000 OCASPS Call American 100 20 BATO 2024-01-19
O:SIBN240119C00017500 OCASPS Call American 100 17.5 BATO 2024-01-19
O:SIBN240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:SIBN240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:SIBN231215P00035000 OPASPS Put American 100 35 BATO 2023-12-15
O:SIBN231215P00030000 OPASPS Put American 100 30 BATO 2023-12-15
O:SIBN231215P00025000 OPASPS Put American 100 25 BATO 2023-12-15
O:SIBN231215P00022500 OPASPS Put American 100 22.5 BATO 2023-12-15
O:SIBN231215P00020000 OPASPS Put American 100 20 BATO 2023-12-15
O:SIBN231215P00017500 OPASPS Put American 100 17.5 BATO 2023-12-15
O:SIBN231215P00015000 OPASPS Put American 100 15 BATO 2023-12-15
O:SIBN231215P00012500 OPASPS Put American 100 12.5 BATO 2023-12-15
O:SIBN231215P00010000 OPASPS Put American 100 10 BATO 2023-12-15
O:SIBN231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:SIBN231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:SIBN231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:SIBN231215C00035000 OCASPS Call American 100 35 BATO 2023-12-15
O:SIBN231215C00030000 OCASPS Call American 100 30 BATO 2023-12-15
O:SIBN231215C00025000 OCASPS Call American 100 25 BATO 2023-12-15
O:SIBN231215C00022500 OCASPS Call American 100 22.5 BATO 2023-12-15
O:SIBN231215C00020000 OCASPS Call American 100 20 BATO 2023-12-15
O:SIBN231215C00017500 OCASPS Call American 100 17.5 BATO 2023-12-15
O:SIBN231215C00015000 OCASPS Call American 100 15 BATO 2023-12-15
O:SIBN231215C00012500 OCASPS Call American 100 12.5 BATO 2023-12-15
O:SIBN231215C00010000 OCASPS Call American 100 10 BATO 2023-12-15
O:SIBN231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:SIBN231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:SIBN231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:SIBN231117P00030000 OPASPS Put American 100 30 BATO 2023-11-17
O:SIBN231117P00025000 OPASPS Put American 100 25 BATO 2023-11-17
O:SIBN231117P00022500 OPASPS Put American 100 22.5 BATO 2023-11-17
O:SIBN231117P00020000 OPASPS Put American 100 20 BATO 2023-11-17
O:SIBN231117P00017500 OPASPS Put American 100 17.5 BATO 2023-11-17
O:SIBN231117P00015000 OPASPS Put American 100 15 BATO 2023-11-17
O:SIBN231117P00012500 OPASPS Put American 100 12.5 BATO 2023-11-17
O:SIBN231117C00030000 OCASPS Call American 100 30 BATO 2023-11-17
O:SIBN231117C00025000 OCASPS Call American 100 25 BATO 2023-11-17
O:SIBN231117C00022500 OCASPS Call American 100 22.5 BATO 2023-11-17
O:SIBN231117C00020000 OCASPS Call American 100 20 BATO 2023-11-17
O:SIBN231117C00017500 OCASPS Call American 100 17.5 BATO 2023-11-17
O:SIBN231117C00015000 OCASPS Call American 100 15 BATO 2023-11-17
O:SIBN231117C00012500 OCASPS Call American 100 12.5 BATO 2023-11-17
O:SIBN231117P00010000 OPASPS Put American 100 10 BATO 2023-11-17
O:SIBN231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:SIBN231117C00010000 OCASPS Call American 100 10 BATO 2023-11-17
O:SIBN231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:SIBN231020P00040000 OPASPS Put American 100 40 BATO 2023-10-20
O:SIBN231020P00035000 OPASPS Put American 100 35 BATO 2023-10-20
O:SIBN231020P00030000 OPASPS Put American 100 30 BATO 2023-10-20
O:SIBN231020P00025000 OPASPS Put American 100 25 BATO 2023-10-20
O:SIBN231020P00022500 OPASPS Put American 100 22.5 BATO 2023-10-20
O:SIBN231020P00020000 OPASPS Put American 100 20 BATO 2023-10-20
O:SIBN231020P00017500 OPASPS Put American 100 17.5 BATO 2023-10-20
O:SIBN231020P00015000 OPASPS Put American 100 15 BATO 2023-10-20
O:SIBN231020P00012500 OPASPS Put American 100 12.5 BATO 2023-10-20
O:SIBN231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:SIBN231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:SIBN231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:SIBN231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:SIBN231020C00040000 OCASPS Call American 100 40 BATO 2023-10-20
O:SIBN231020C00035000 OCASPS Call American 100 35 BATO 2023-10-20
O:SIBN231020C00030000 OCASPS Call American 100 30 BATO 2023-10-20
O:SIBN231020C00025000 OCASPS Call American 100 25 BATO 2023-10-20
O:SIBN231020C00022500 OCASPS Call American 100 22.5 BATO 2023-10-20
O:SIBN231020C00020000 OCASPS Call American 100 20 BATO 2023-10-20
O:SIBN231020C00017500 OCASPS Call American 100 17.5 BATO 2023-10-20
O:SIBN231020C00015000 OCASPS Call American 100 15 BATO 2023-10-20
O:SIBN231020C00012500 OCASPS Call American 100 12.5 BATO 2023-10-20
O:SIBN231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:SIBN231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:SIBN231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:SIBN231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:SIBN230915P00035000 OPASPS Put American 100 35 BATO 2023-09-15
O:SIBN230915P00030000 OPASPS Put American 100 30 BATO 2023-09-15
O:SIBN230915P00025000 OPASPS Put American 100 25 BATO 2023-09-15
O:SIBN230915P00022500 OPASPS Put American 100 22.5 BATO 2023-09-15
O:SIBN230915P00020000 OPASPS Put American 100 20 BATO 2023-09-15
O:SIBN230915P00017500 OPASPS Put American 100 17.5 BATO 2023-09-15
O:SIBN230915P00015000 OPASPS Put American 100 15 BATO 2023-09-15
O:SIBN230915C00035000 OCASPS Call American 100 35 BATO 2023-09-15
O:SIBN230915C00030000 OCASPS Call American 100 30 BATO 2023-09-15
O:SIBN230915C00025000 OCASPS Call American 100 25 BATO 2023-09-15
O:SIBN230915C00022500 OCASPS Call American 100 22.5 BATO 2023-09-15
O:SIBN230915C00020000 OCASPS Call American 100 20 BATO 2023-09-15
O:SIBN230915C00017500 OCASPS Call American 100 17.5 BATO 2023-09-15
O:SIBN230915C00015000 OCASPS Call American 100 15 BATO 2023-09-15
O:SIBN230915P00012500 OPASPS Put American 100 12.5 BATO 2023-09-15
O:SIBN230915C00012500 OCASPS Call American 100 12.5 BATO 2023-09-15
O:SIBN230818P00040000 OPASPS Put American 100 40 BATO 2023-08-18
O:SIBN230818P00035000 OPASPS Put American 100 35 BATO 2023-08-18
O:SIBN230818P00030000 OPASPS Put American 100 30 BATO 2023-08-18
O:SIBN230818P00025000 OPASPS Put American 100 25 BATO 2023-08-18
O:SIBN230818P00022500 OPASPS Put American 100 22.5 BATO 2023-08-18
O:SIBN230818P00020000 OPASPS Put American 100 20 BATO 2023-08-18
O:SIBN230818P00017500 OPASPS Put American 100 17.5 BATO 2023-08-18
O:SIBN230818P00015000 OPASPS Put American 100 15 BATO 2023-08-18
O:SIBN230818C00040000 OCASPS Call American 100 40 BATO 2023-08-18
O:SIBN230818C00035000 OCASPS Call American 100 35 BATO 2023-08-18
O:SIBN230818C00030000 OCASPS Call American 100 30 BATO 2023-08-18
O:SIBN230818C00025000 OCASPS Call American 100 25 BATO 2023-08-18
O:SIBN230818C00022500 OCASPS Call American 100 22.5 BATO 2023-08-18
O:SIBN230818C00020000 OCASPS Call American 100 20 BATO 2023-08-18
O:SIBN230818C00017500 OCASPS Call American 100 17.5 BATO 2023-08-18
O:SIBN230818C00015000 OCASPS Call American 100 15 BATO 2023-08-18
O:SIBN230818P00012500 OPASPS Put American 100 12.5 BATO 2023-08-18
O:SIBN230818C00012500 OCASPS Call American 100 12.5 BATO 2023-08-18
News Stream
Calendar Calendar of Events
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024
SANTA CLARA, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2024 BofA Securities Healthcare Conference in Las Vegas. Management will be hosting a fireside chat on Tuesday, May 14, at 2:20 p.m. Eastern Time / 11:20 a.m. Pacific Time.
GlobeNewswire Inc. • 2w ago
Analyst Analyst Ratings
Peeling Back The Layers: Exploring SI-BONE Through Analyst Insights
In the last three months, 4 analysts have published ratings on SI-BONE (NASDAQ:SIBN), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 2 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $25.0, a high estimate of $26.00, and a low estimate of $24.00. A decline of 1.3% from the prior average price target is evident in the current average. Diving into Analyst Ratings: An In-Depth Exploration A comprehensive examination of how financial experts perceive SI-BONE is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Matt O'Brien Piper Sandler Announces Overweight $25.00 - Drew Ranieri Morgan Stanley Raises Overweight $26.00 $25.00 Ross Osborn Cantor Fitzgerald Maintains Overweight $25.00 $25.00 Samuel Brodovsky Truist Securities Lowers Buy $24.00 $26.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent ...Full story available on Benzinga.com
Benzinga • 1mo ago
Calendar Calendar of Events
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Barclays 26th Annual Global Healthcare Conference in Miami. Management will be hosting a fireside chat on Tuesday, March 12, at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time.
GlobeNewswire Inc. • 2mo ago
Analyst Analyst Ratings
Beyond The Numbers: 4 Analysts Discuss SI-BONE Stock
SI-BONE (NASDAQ:SIBN) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 1 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 2 0 0 0 0 Analysts have recently evaluated SI-BONE and provided 12-month price targets. The average target is $25.0, accompanied by a high estimate of $26.00 and a low estimate of $24.00. Highlighting a 1.3% decrease, the current average has fallen from the previous average price target of $25.33. Interpreting Analyst Ratings: A Closer Look An in-depth analysis of recent analyst actions unveils how financial experts perceive SI-BONE. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Ross Osborn Cantor Fitzgerald Maintains Overweight $25.00 $25.00 Samuel Brodovsky Truist Securities Lowers Buy $24.00 $26.00 David Rescott Truist Securities Raises Buy $26.00 $25.00 David Saxon Needham Maintains Buy $25.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to SI-BONE. This information provides a ...Full story available on Benzinga.com
Benzinga • 2mo ago
Stocks Earnings Releases and Operating Results
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the fourth quarter and full year ended December 31, 2023.
GlobeNewswire Inc. • 2mo ago
News News
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Zacks Investment Research • 2mo ago
News News
Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Si-Bone (SIBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research • 2mo ago
Calendar Calendar of Events
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
SANTA CLARA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Monday, February 26, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
GlobeNewswire Inc. • 3mo ago
News News
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Zacks Investment Research • 3mo ago
News Product / Services Announcement
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application
SANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announces FDA 510(k) premarket clearance of the iFuse Bedrock Granite® Implant System (Granite) in a smaller (9.5 mm) diameter with both an expanded indication in pediatric patients and an expanded application that includes use in the S1 trajectory. When placed across the SI joint, the Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for multi-segment spinal fusion.
GlobeNewswire Inc. • 3mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT